POSTER SESSION 4

1

(AHE)

AN INTEGRATED SIMULATION MODEL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Amory B. Schlender, BA, Archimedes, Inc., San Francisco, CA

2

(HSP)

* THE ECONOMY AND SUICIDES: MEDICAID'S IMPACT ON THE MENTAL HEALTH INDUSTRY

Lawrence C. Pellegrini, MSW, MPA and Rosa Rodriguez-Monguio, PhD, University of Massachusetts, Amherst -School of Public Health and Health Sciences, Amherst, MA

3

(INF, AHE)

COST EFFECTIVENESS OF A GENE EXPRESSION SCORE AND MYOCARDIAL PERFUSION IMAGING FOR DIAGNOSIS OF CORONARY ARTERY DISEASE

Charles E. Phelps¹, Pamela S. Douglas², Amy K. O'Sullivan, PhD³, Morgan Deflin, BS⁴, Kevin Leahy, BA³, Michael R. Elashoff⁵, Mark Monane⁶ and Joseph Ladapo, MD, PhD⁷, (1)University of Rochester, Gualala, CA, (2)Duke University, Durham, NC, (3)OptumInsight, Eden Prarie, MN, (4)OptumInsight, San Francisco, CA, (5)CardioDx, Inc, Palo Alto, CA, (6)CardioDx, Inc., Palo Alto, CA, (7)NYU School of Medicine, NY, NY

4

(AHE)

COSTS OF ACUTE MYOCARDIAL INFARCTION HOSPITALIZATIONS FOR PATIENTS AGED 18-64 YEARS IN THE UNITED STATES

Guijing Wang, PhD, Centers for Disease Control and Prevention, Atlanta, GA

5

(DEC)

INDIVIDUAL CHARACTERISTICS ASSOCIATED WITH DIFFERENCES IN DESIRE FOR LUNG CANCER SCREENING

Margaret M. Byrne, PhD¹, Richard Thurer¹, Mark S. Roberts, MD, MPP² and Jamie L. Studts, PhD³, (1)University of Miami, Miami, FL, (2)University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, (3)University of Kentucky College of Medicine, Lexington, KY

6

(INF, AHE)

COST-EFFECTIVENESS OF TREATMENT EFFECT AND TREATMENT-PREFERENCE EFFECT OF COGNITIVE BEHAVIORAL THERAPY VERSUS PHARMACOTHERAPY IN POST-TRAUMATIC STRESS DISORDER (PTSD)

Quang A. Le, PharmD, PhD, Western University of Health Sciences, Pomona, CA, Jason N. Doctor, PhD, University of Southern California, Los Angeles, CA, Lori Zoellner, PhD, University of Washington, Seattle, WA and Norah Feeny, PhD, Case Western Reserve University, Cleveland, OH

7

(HSP)

ANALYSING COSTS, OUTCOMES, AND PROCESSES: A FRAMEWORK FOR REDUCING IMPORTANT VARIATIONS IN CLINICAL PRACTICE

Jonathan Karnon, PhD¹, Andrew Partington, BSc, (Hons)¹, Glenis J. Crane, PhD¹, Matthew Horsfall, RN², Derek Chew, MBBS, MPH, FRACP³, David I. Ben-Tovim, MBBS, PhD⁴ and Paul Hakendorf, BSc, MPH⁴, (1)University of Adelaide, Adelaide, Australia, (2)South Australian Health and Medical Research Institute, Adelaide, Australia, (3)Flinders University, Adelaide, Australia, (4)Flinders Medical Centre, Adelaide, Australia

8

(AHE)

A PROSECTIVE STUDY ON COSTS TO INSURANCE AND OUT-OF-POCKET COSTS OF COCHLEAR IMPLANTATION COMPARED WITH HEARING AIDS IN NEWLY IMPLANTED ADULT RECIPIENTS

Leslie S. Wilson, PhD, University of Californai San Francisco, San Francisco, CA, Jan Gilden, MA, Houston Ear Research Foundation, Houston, TX and Kathryn Henion, Cochlear Americas, Englewood, CO

9

(DEC)

REAL-TIME LOCATION SYSTEMS, NORMATIVE MESSAGING AND CHANGING CLINICIAN BEHAVIOR

James Stahl, MD, CM, MPH, Massachusetts General Hospital, Boston, MA and Mark A. Drew, BID, Massacuhsetts General Hospital, Boston, MA

10

(HSP)

IN-GROUP/OUT-GROUP – DOES IT MAKE A DIFFERENCE? GENDER, ETHNICITY, RACE AND FACE-TIME

James Stahl, MD, CM, MPH, Massachusetts General Hospital, Boston, MA and Mark A. Drew, BID, Massacuhsetts General Hospital, Boston, MA

11

(DEC)

PREDICTORS OF TREATMENT ESCALATION IN CLINICAL PRACTICE

Liana Fraenkel, MD, MPH¹, Meaghan Cunnigham, MPH¹ and Paul R. Falzer, PhD², (1)Yale School of Medicine, New Haven, CT, (2)VA Connecticut HealthCare System, West Haven, CT

12

(HSP)

LEARNING FROM TEXT MINING IN MEDICAL CARE MANAGEMENT NOTES

Scott Zasadil, Ph.D. and Pamela Peele, Ph.D., UPMC Health Plan, Pittsburgh, PA

13

(HSP)

MIXED MESSAGES: DIVERGENT RESULTS IN CARDIOVASCULAR CLINICAL TRIALS

Robert J. Bryg, MD, Cardiology, Sylmar, CA and David J. Bryg, PhD, Olive View-Medical Center, Sylmar, CA

15

(DEC)

PHYSICIANS' JUDGMENTS OF RADIOLOGICAL IMAGES ON A MULTI-TRIAL DISCRIMINATION TASK: EVIDENCE FOR THE USE OF COGNITIVE HEURISTICS

Jason W. Beckstead, PhD, University of South Florida College of Nursing, Tampa, FL, Kathy Boutis, BSc, MSc, MD, FRCPC, Hospital for Sick Children, Toronto, ON, Canada, Martin R. Pecaric, PhD, Contrail Consulting Services, Toronto, ON, Canada and Martin V. Pusic, MD, PhD, New York University, New York, NY

16

(DEC)

THE IMPACT OF CURRENT ILLICIT DRUG USE ON QUALITY OF LIFE IN HIV INFECTED AND AT RISK WOMEN: IMPLICATIONS FOR COMBINED HEALTH UTILITIES

Brandon Aden, MD, MPH¹, Bohdan Nosyk, Ph.D.², Bruce R. Schackman, PhD¹ and Eve Wittenberg, MPP, PhD³, (1)Weill Cornell Medical College, New York, NY, (2)Simon Fraser University - Faculty of Health Sciences, Vancouver, BC, Canada, (3)Harvard School of Public Health, Boston, MA

17

(DEC)

THE EFFECT OF NARRATIVE FORMAT ON INFORMATION SEARCH USING A WEB-BASED BREAST CANCER DECISION AID

Victoria A. Shaffer, PhD, University of Missouri-Columbia, Columbia, MO, Justin Owens, MA, Wichita State University, Wichita, KS and Brian J. Zikmund-Fisher, PhD, University of Michigan, Ann Arbor, MI

18

(AHE)

DISCONTINUATION OF ORAL 5-AMINOSALICYLIC ACID THERAPY ASSOCIATED WITH INCREMENTAL ALL-CAUSE HEALTHCARE COSTS IN ACTIVE ULCERATIVE COLITIS PATIENTS

Michael B. Nichol, PhD¹, Joanne Wu, MD, MS¹ and Linnette Yen², (1)University of Southern California, Los Angeles, CA, (2)Shire Development LLC, Wayne, PA

19

(HSP)

HOW DECISIONS ON TUBERCULOSIS CARE UTILIZATION AND PLACE OF WORK AMONG MIGRANT WORKERS FROM ARMENIA IMPACT TB HEALTH OUTCOMES

Nune Truzyan, DVM, MPH, Varduhi Petrosyan, MS, PhD, Byron Crape, MSPH, PhD and Ruzanna Grigoryan, MD, MPH, American University of Armenia, Yerevan, Armenia

20

(DEC)

BARRIERS AND FACILITATORS TO IMPLEMENT SHARED DECISION MAKING IN TREATMENT OF SCIATICA PATIENTS

Stefanie N. Hofstede, MSc, P.J. Marang-van de Mheen, PhD, Anne M. Stiggelbout, PhD, Willem J.J. Assendelft, MD, PhD, Manon M. Wentink, MSc, Thea P.M. Vliet Vlieland, MD, PhD and Leti van Bodegom-Vos, PhD, Leiden University Medical Center, Leiden, Netherlands

21

(AHE)

NEGOTIATED RATES FOR OUTPATIENT SERVICES: FINDING CONSIDERABLE VARIANCE EVEN WITHIN A SINGLE COMMERCIAL CARRIER'S NETWORK

Sophie Pinkard, MBA¹, Dena M. Bravata, MD, MS², Bob Kocher, MD¹ and Jennifer Schneider Chafen, M.D., M.S.³, (1)Castlight Health, San Francisco, CA, (2)Castlight Health, Stanford, CA, (3)Stanford Center for Primary Care and Outcomes Research, Stanford, CA

22

(HSP)

PEDIATRIC ENTERAL ACCESS PROCEDURES IN THE U.S.: REGIONAL VARIATION AND CHANGING RATES

David Fox, MD, University of Colorado, Denver, Aurora, CO, Elizabeth Campagna, MS, Children's Outcomes Research Program, Aurora, CO and Allison Kempe, MD, MPH, Children's Outcome Research Program, Denver, CO

23

(INF, AHE)

DEVELOPMENT OF A MARKOV MODEL TO EVALUATE TREATMENTS OF ALCOHOL ABUSE

Richard M. Zur, Ph.D., The University of Western Ontario, London, ON, Canada and Gregory S. Zaric, Ph.D, University of Western Ontario, London, ON, Canada

24

(DEC)

RELIABILITY OF AN ONLINE DECISION AID FOR ADVANCE CARE PLANNING: AN APPLICATION OF GENERALIZABILITY THEORY

Jane R. Schubart, PhD, MS, MBA, Fabian Camacho, MS, Benjamin H. Levi, MD, PhD, Kimberly Rush, MS and Michael J. Green, MD, MS, Penn State College of Medicine, Hershey, PA

25

(HSP)

MANAGEMENT OF UNDESCENDED TESTIS: A DECISION ANALYSIS

M.Elske Akker-van Marle, PhD¹, Mascha Kamphuis, MD, PhD², Helma B.M. van Gameren-Oosterom, MD², Frank H. Pierik, PhD³ and Job Kievit, MD, PhD¹, (1)Leiden University Medical Center, Leiden, Netherlands, (2)Netherlands Organization for Applied Scientific Research, Leiden, Netherlands, (3)Netherlands Organization for Applied Scientific Research, Delft, Netherlands

26

(HSP)

UTILIZATION OF USTEKINUMAB IN BIOLOGIC-EXPERIENCED AND BIOLOGIC-NAïVE PSORIASIS PATIENTS

Chureen T. Carter, PharmD, MS¹, Zhun Cao, Phd², Kathleen Wilson², Silas Martin¹ and Brad Schenkel¹, (1)Janssen Scientific Affairs, LLC, Horsham, PA, (2)Thomson Reuters, Cambridge, MA

27

(HSP)

INTEGRATING THE PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS) SYMPTOM ASSESSMENT INTO ROUTINE CANCER CARE

Lynne I. Wagner, Ph.D.¹, Laura A. Abraham¹, Kile King¹, Shalini N. Patel¹, Michael Bass, MS¹, Maria Varela Diaz¹, Nan Rothrock, Ph.D.¹, Julian Schink, M.D.², Richard Gershon, PhD¹ and David Cella, PhD¹, (1)Northwestern University Feinberg School of Medicine, Chicago, IL, (2)Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL

28

(AHE)

USING LARGE, RETROSPECTIVE DATASETS TO MAKE COST-EFFECTIVE DECISIONS CONCERNING EMBRYO TRANSFER POLICIES IN FIRST CYCLE IN VITRO FERTILIZATION PATIENTS WHO ARE 38 YEARS OF AGE OR OLDER: A POPULATION-BASED ANALYSIS

Christopher Jones, D.Phil., University of Vermont, College of Medicine, Burlington, VT and Renju Raj, MD, University Of Vermont College of Medicine, Burlington, VT

29

(INF, AHE)

COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN ACUTE CORONARY SYNDROME PATIENTS IN COLOMBIA

Martin Romero, Angie Upegui and Diana Chavez, Salutia Foundation, Bogotá D.C, Colombia

30

(DEC)

ILLOGICAL RESPONSES FOR JOINT HEALTH STATE UTILITIES; A COMPARISON OF TIME-TRADEOFFS AND STANDARD GAMBLE METHODS

Joshua Hemmerich, PhD¹, Arthur Elstein, PhD², Eva Melstrom, BA³ and William Dale, MD, PhD¹, (1)University of Chicago, Chicago, IL, (2)The University of Illinois at Chicago, Wilmette, IL, (3)The University of Chicago, Chicago, IL

31

(INF, AHE)

TREATING PATIENTS IN HAPO GLUCOSE CATEGORY 5 TO IMPROVE MATERNAL AND NEONATAL OUTCOMES: A COST EFFECTIVENESS ANALYSIS

John F. Mission¹, Mika Ohno, MD², Keenan Yanit, MD¹, Yvonne Cheng, MD, MPH³ and Aaron B. Caughey, MD, MPP, MPH, PhD⁴, (1)Oregon Health and Science University, Portland, OR, (2)Santa Clara Valley Medical Center, Sunnyvale, CA, (3)University of California, San Francisco, CA, (4)Oregon Health & Sciences University, Portland, OR

32

(HSP)

WHAT PROFESSIONAL ACTIVITIES DO GENERAL PRACTITIONERS FIND MOST MEANINGFUL, AND ARE THEY AT ODDS WITH THE REQUIREMENTS OF HEALTH CARE REFORMS? CROSS SECTIONAL SURVEY OF NORWEGIAN GPS

Peder A. Halvorsen, MD, PhD¹, Adrian Edwards, MB, PhD², Ivar J. Aaraas, MD, PhD¹, Olaf Gjerløw Aasland, MD, PhD³ and Ivar Sønbø Kristiansen, MD, PhD, MPH⁴, (1)University of Tromsø, Tromsø, Norway, (2)Cardiff University, Cardiff, United Kingdom, (3)The Norwegian Medical Association, Oslo, Norway, (4)University of Oslo, Oslo, Norway

33

(DEC)

EXPLICIT ATTITUDES SEEM MORE DECISIVE FOR INTENTIONS ABOUT CERVICAL CANCER SCREENING THAN IMPLICIT ATTITUDES

Ida J. Korfage, MSc, PhD¹, Erik W. de Kwaadsteniet, MSc, PhD², Arwen H. Pieterse, PhD³, Anne M. Stiggelbout, PhD³ and Marieke de Vries, PhD⁴, (1)Erasmus MC - University Medical Center, Rotterdam, Netherlands, (2)Leiden University, Leiden, Netherlands, (3)Leiden University Medical Center, Leiden, Netherlands, (4)Tilburg University, Tilburg, Netherlands

34

(DEC)

DEVELOPING VIRTUAL PATIENT ADVOCATE TECHNOLOGY FOR SHARED DECISION MAKING

Suzanne E. Mitchell, MD, MS¹, Cathryn Imperato, RN, DNP², Daniel Schulman², MEgan Hempstead¹, Huong Tran, MD¹, Meryl Kopy, MA¹, Timothy Bickmore, PhD², Michael K. Paasche-orlow, MD, MPH¹ and Brian Jack, MD¹, (1)Boston University School of Medicine, Boston, MA, (2)Northeastern University, Boston, MA

35

(DEC)

PATIENT CHARACTERISTICS ASSOCIATED WITH PREFERENCE PATTERNS AND MESSAGING FRAMES FOR DEPRESSION TREATMENT

Marsha Wittink, MD, MBE, University of Rochester School of Medicine, Rochester, NY, Mark Cary, Ph.D., University of Pennsylvania School of Medicine, Philadelphia, PA and Joseph Gallo, MD, MPH, Johns Hopkins University, Baltimore, MD

36

(DEC)

MEN'S PREFERENCES FOR PROSTATE CANCER SCREENING: A DISCRETE CHOICE EXPERIMENT

Esther W. de Bekker-Grob, PhD¹, Bas Donkers, PhD², John M. Rose, PhD³, Marie-Louise Essink-Bot, MD, PhD⁴, Chris H. Bangma, MD, PhD¹ and Ewout W. Steyerberg, PhD¹, (1)Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands, (2)Erasmus University Rotterdam, Rotterdam, Netherlands, (3)University of Sydney, Sydney, Australia, (4)Social Medicine, Amsterdam, Netherlands

37

(AHE)

ECONOMIC BENEFIT OF AN EDUCATIONAL INTERVENTION TO IMPROVE TPA USE IN COMMUNITY HOSPITALS

David W. Hutton, PhD¹, Cemal B. Sozener, MD², William Meurer², Shirley Frederiksen², Allison Kade² and Phillip A. Scott, MD², (1)University of Michigan School of Public Health, Ann Arbor, MI, (2)University of Michigan, Ann Arbor, MI

38

(INF, HSP)

METHODS FOR EVALUATING STRATEGIES FOR RAPID RESPONSE TEAMS IN HOSPITAL SETTINGS

Bruce W. Morlan, MS, Jeanne Huddleston, MD, James M. Naessens, ScD, Matthew G. Johnson, MS and Joel A. Hickman, Mayo Clinic, Rochester, MN

39

(DEC)

ENHANCING THE CONVERSATION: INCORPORATING INFORMATION ABOUT THE PATIENT'S IMMEDIATE ENVIRONMENT INTO DECISION MAKING

Heather L. Black, Ph.D., Merck Sharp & Dohme Corp., North Wales, PA

40

(DEC)

DO VALID FILM DECISION-AIDS INFORM PARENTS ON POTENTIAL OUTCOMES OF EXTREME PREMATURITY WITHOUT CREATING STRESS?

Ursula Guillen, MD¹, Sanghee Suh, BS², Eileen Wang, MD³, Veronica Stickelman, MA⁴ and Haresh Kirpalani, BM, MSc², (1)Children's Hospital of Philadelphia, Wilmington, DE, (2)Children's Hospital of Philadelphia, Philadelphia, PA, (3)University of Pennsylvania, Philadelphia, PA, (4)Philadelphia Women in Film and Television, Philadelphia, PA

42

(HSP)

ARE ORGANIC FOODS SAFER OR HEALTHIER THAN CONVENTIONAL ALTERNATIVES? A SYSTEMATIC REVIEW

Crystal M. Smith-Spangler, MD, MS¹, Margaret L. Brandeau, PhD², James C. Bavinger, BA², Grace E. Hunter, BA, MSc.³, Paul Eschbach², Maren Pearson², Vandana Sundaram, MPH¹, Hau Liu, MD, MS, MBA, MPH⁴, Patricia Schirmer, MD⁵, Christopher Stave, MLS², Ingram Olkin, PhD⁶ and Dena M. Bravata, MD, MS², (1)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA, (2)Stanford University, Stanford, CA, (3)Stanford University, San Francisco, CA, (4)Santa Clara County Medical Center, San Jose, CA, (5)Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, (6)Stanford University, Palo Alto, CA

43

(HSP)

TRUST AND COMPARATIVE EFFECTIVENESS RESEARCH: METHODS, POLICIES, AND FUTURE DIRECTIONS FOR REPRODUCIBLE RESEARCH

Crystal M. Smith-Spangler, MD, MS, Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA and Steven Goodman, MD, PhD, Stanford University, Stanford, CA

44

(HSP)

EMPOWERING PATIENT DECISION MAKING AND HEALTH MANAGEMENT: EVALUATING INDIVIDUAL PREFERENCES AND WILLINGNESS TO ADOP HEALTH INFORMATION TECHNOLOGIES

Sara Ahmed, PhD and Iphigenia Symeonidis, M.A., McGill University, Montreal, QC, Canada

45

(HSP)

PRELIMINARY OUTCOMES TOWARDS A RISK-BASED MICROSIMULATION DECISION-ANALYTICAL MODEL BASED ON TREATMENT AND COST INPUTS FROM A REAL WORLD COHORT OF BREAST CANCER PATIENTS

Beate Jahn, PhD¹, David Stenehjem, PharmD², Kim Saverno, PhD³, Beilei Cai, PhD⁴, Uwe Siebert, MD, MPH, MSc, SD⁵ and Diana Brixner, PhD², (1)UMIT - University for Health Sciences, Medical Informatics and Technology, ONCOTYROL - Center for Personalized Cancer Medicine, Hall in Tirol, Austria, (2)University of Utah, Salt Lake City, UT, (3)UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria, (4)Pharmacotherapy Outcome Research Center, Salt Lake City, UT, (5)UMIT - University for Health Sciences; ONCOTYROL - Center for Personalized Cancer Medicine; Harvard Univ (HSPH/HMS), Hall, Austria

46

(DEC)

THE IMPACT OF AFFECTIVE AND COGNITIVE EVALUATIONS ON PREGNANT WOMEN'S DECISIONS ABOUT PRENATAL SCREENING

Danielle R.M. Timmermans, PhD, EMGO Institute/ VU University Medical Center, Amsterdam, Netherlands

47

(DEC)

DOES TIME FRAME MATTER? COMMUNICATING AGE-RELATED OR LIFETIME RISKS IN BREAST CANCER RISK COMMUNICATION

Danielle R.M. Timmermans, PhD¹, Christi J. Van Asperen, MD, PhD², Jan C. Oosterwijk, MD, PhD³, Fred H. Menko, MD, PhD⁴, Liesbeth Claassen, PhD¹ and Lidewij Henneman, PhD¹, (1)EMGO Institute/ VU University Medical Center, Amsterdam, Netherlands, (2)Leiden University Medical Center, Leiden, Netherlands, (3)University Medical Center Groningen, Groningen, Netherlands, (4)VU University Medical Center, Amsterdam, Netherlands

48

(DEC)

RISK COMMUNICATION IN THE DUTCH CANCER RISK TEST: THE MORE NUMBERS THE BETTER, OR NOT?

Danielle R.M. Timmermans, PhD, EMGO Institute/ VU University Medical Center, Amsterdam, Netherlands and J. Oudhoff, PhD, VU University Medical Center, Amsterdam, Netherlands

49

(INF, AHE)

COST EFFECTIVENESS OF STRATEGIES FOR DIAGNOSIS OF HEPATITIS C IN MEXICO

Víctor Granados-García, MPhil¹, Ana M. Contreras, Dr², Rodolfo J. Ochoa-Jiménez, Dr³, Alfredo Celis, Dr², Edgar Hernández-Urbina, Dr² and Nancy B. Sanchez-Tomay, Dr², (1)Mexican Institute of Social Security, Mexico City, Mexico, (2)Mexican Institute of Social Security, Guadalajara, Mexico, (3)Mexican Institute of Social Security, Colima, Mexico

50

(HSP)

USING DISASTER PREPAREDNESS PRINCIPLES TO IMPROVE MEDICAL EDUCATION AND HEALTH CARE PERFORMANCE OUTCOMES

Rebecca Roberts, MD¹, Robert Humrickhouse², Michelle Sergel, MD¹, Suja Mathew, MD¹, Saini Raj Kundapati, MD¹, Rashid Kysia, MD¹, Helen Straus, MD¹, Isam Nasr, MD¹ and Ibrar Ahmad, BS¹, (1)Cook County Hospital (Stroger), Chicago, IL, (2)Metropolitan Chicago Healthcare Council, Chicago, IL

51

(HSP)

CAN PLOTTING CLINICAL TREATMENT RESPONSE RATES AND CALCULATING DISEASE SLOPES OVER TIME IMPROVE MEDICAL DECISION MAKING?

Rebecca Roberts, MD¹, Shawn Prakash, MD², Nabiha Shamsi, BS³, Linda Kampe, MPH⁴, Ibrar Ahmad, BS¹, Emma Lewis, BA⁵, Omer Naseer, MD⁶, Roger Roxas, MA¹ and Masoumeh Shirani, MD⁷, (1)Cook County Hospital (Stroger), Chicago, IL, (2)New York Medical College, New York, NY, (3)University of Illinois at Chicago, Chicago, IL, (4)Cook County Hospital and Healthcare System, Chicago, IL, (5)Barnard College, New York, NY, (6)Metropolitan Westchester Medical Center, New York, NY, (7)Cook County Hospital (Stroger Hospital), Chicago, IL

52

(DEC)

ONLINE IMMUNIZATION SCHEDULE DECISION SUPPORT TOOL PRESENTS SHARED RISK ASSESSMENT AND COMMUNICATION OPPORTUNITIES FOR PROVIDERS AND PATIENTS

Sheila Isbell, M.S., C.S. and D. Scott Appling, M.S., C.S., Georgia Institute of Technology, Atlanta, GA

53

(DEC)

REDUCING TRIPLET GESTATIONS: A DECISION ANALYSIS

Rachel A. Pilliod¹, Jessica M. Page¹, Katherine Volpe¹, Keenan Yanit¹, Leonardo Pereira, MD¹, Alison Cahill, MD² and Aaron B. Caughey, MD, MPP, MPH, PhD¹, (1)Oregon Health and Science University, Portland, OR, (2)Washington University, St. Louis, MO

54

(HSP)

ASSESSING THE IMPACT OF ADVOCACY AND PUBLIC AWARENESS ON NATIONAL PRIORITIES FOR LIVER CANCER CONTROL

John F.P. Bridges, PhD¹, Susan Joy, MPH, MA¹ and Barri M. Blauvelt, MBA², (1)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)University of Massachusetts, Hadley, ME

55

(HSP)

IDENTIFYING OPERATIONAL FACTORS AFFECTING PATIENTS' UNDERSTANDING OF TREATMENT

Jessica J. Chen, MD, University of California at San Diego, Escondido, CA and John Fontanesi, PhD, UCSD School of Medicine, Solana Beach, CA

56

(HSP)

PREDICTORS OF PROSTATE CANCER SCREENING: A MULTILEVEL MODELING APPROACH

Vishvas Garg, MBA, BPharmacy, Dennis Raisch, PhD and James Selig, PhD, MA, University of New Mexico, Albuquerque, NM

57

(HSP)

UNCERTAINTY IN BARRETT'S ESOPHAGUS PROGRESSION RATES: IMPACT ON THE EFFICIENCY OF SCREENING AND ABLATION

S. Kroep¹, I. Landsdorp-Vogelaar¹, J.M. Inadomi² and M. van Ballegooijen¹, (1)Erasmus MC, University Medical Center, Rotterdam, Netherlands, (2)University of Washington, Seattle, WA